Hiroyuki Shimada

5PUBLICATIONS
74CO-AUTHORS
Predictive and prognostic markersHaematological tumoursElectrochemical energy storage and conversionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 27, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group.

Florette K Hazard, Angus M S Toland, Serena Y Tan

|Jul 14, 2025
Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma.

Marie Ménard, Hiroyuki Yoda, Nicole Nasholm

|Feb 24, 2025
Data set for reporting of peripheral neuroblastic tumours: recommendations from the international collaboration on cancer reporting (ICCR).

Jason A Jarzembowski, Fleur Webster, Klaus Beiske

|Nov 01, 2022
Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma.

Haowen Jiang, Rachel L Greathouse, Sarah Jane Tiche

|Jul 15, 2022
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group.

Ami V Desai, Andrew L Gilman, Mehmet Fevzi Ozkaynak

Pageof 1

Frequent Collaborators

3 joint publications

Susan L Cohn

3 joint publications

John M Maris

2 joint publications

Shahab Asgharzadeh

2 joint publications

Arlene Naranjo